These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 18496615)
1. Perceptions of acceptability and utility of microbicides in Ghana, West Africa: a qualitative, exploratory study. Tanner AE SAHARA J; 2008 Apr; 5(1):11-8. PubMed ID: 18496615 [TBL] [Abstract][Full Text] [Related]
2. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya. Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553 [TBL] [Abstract][Full Text] [Related]
3. An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana. Abdulai MA; Baiden F; Adjei G; Afari-Asiedu S; Adjei K; Tawiah C; Newton S BMC Womens Health; 2012 Nov; 12():40. PubMed ID: 23114222 [TBL] [Abstract][Full Text] [Related]
4. Educating men about vaginal microbicides: considerations from Kenya. Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426 [TBL] [Abstract][Full Text] [Related]
5. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106 [TBL] [Abstract][Full Text] [Related]
6. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction. Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618 [TBL] [Abstract][Full Text] [Related]
7. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction. Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845 [TBL] [Abstract][Full Text] [Related]
8. The role of partnership dynamics in determining the acceptability of condoms and microbicides. Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176 [TBL] [Abstract][Full Text] [Related]
10. Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention. Weeks MR; Mosack KE; Abbott M; Sylla LN; Valdes B; Prince M Sex Transm Dis; 2004 Nov; 31(11):682-90. PubMed ID: 15502677 [TBL] [Abstract][Full Text] [Related]
11. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting. Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431 [TBL] [Abstract][Full Text] [Related]
12. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa. Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545 [No Abstract] [Full Text] [Related]
13. [Current status of the female condom in Africa]. Deniaud F Sante; 1997; 7(6):405-15. PubMed ID: 9503499 [TBL] [Abstract][Full Text] [Related]
14. Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection. Hoel N; Shaikh S; Kagee A Ethn Health; 2011 Apr; 16(2):89-106. PubMed ID: 21328113 [TBL] [Abstract][Full Text] [Related]
15. Young Women's use of a microbicide surrogate: the complex influence of relationship characteristics and perceived male partners' evaluations. Tanner AE; Fortenberry JD; Zimet GD; Reece M; Graham CA; Murray M Arch Sex Behav; 2010 Jun; 39(3):735-47. PubMed ID: 19224355 [TBL] [Abstract][Full Text] [Related]
16. Acceptability of a microbicide among women and their partners in a 4-country phase I trial. Bentley ME; Fullem AM; Tolley EE; Kelly CW; Jogelkar N; Srirak N; Mwafulirwa L; Khumalo-Sakutukwa G; Celentano DD Am J Public Health; 2004 Jul; 94(7):1159-64. PubMed ID: 15226137 [TBL] [Abstract][Full Text] [Related]
18. A social ecology of rectal microbicide acceptability among young men who have sex with men and transgender women in Thailand. Newman PA; Roungprakhon S; Tepjan S J Int AIDS Soc; 2013 Aug; 16(1):18476. PubMed ID: 23911116 [TBL] [Abstract][Full Text] [Related]
19. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding". Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076 [TBL] [Abstract][Full Text] [Related]
20. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms. Weinrib R; Browne EN; Shapley-Quinn MK; van der Straten A; Beksinska M; Mgodi N; Musara P; Mphili N; Schwartz JL; Ju S; Hanif H; Montgomery ET; AIDS Behav; 2020 Feb; 24(2):637-647. PubMed ID: 31254190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]